It's winner, winner Christmas ham dinner for the German retailer.
(Bloomberg) -- Australia’s economy bounced back to growth in the three months through September with households resuming spending as restrictions eased, underscoring the Reserve Bank’s view that the nation has turned the corner.Gross domestic product expanded 3.3% from the second quarter, when it tumbled by 7%, the Australian Bureau of Statistics said in Sydney Wednesday. Economists had forecast a 2.5% expansion. From a year earlier, the economy shrank 3.8% versus an estimated 4.4% contraction.“We are now expecting GDP growth to be solidly positive in both the September and December quarters,” RBA Governor Philip Lowe told a parliamentary panel in Canberra today. “These figures, though, cannot hide the reality that the recovery will be uneven and bumpy and that it will be drawn out. Some parts of the economy are doing quite well, but others are in considerable difficulty.”The renewed expansion shows how resilient the economy was outside the southeastern state of Victoria, which was under one of the world’s toughest lockdowns for much of the period. The RBA and government delivered significant stimulus early in the pandemic to help households and firms.The Australian dollar rose after the report, before edging back down to trade at 73.69 U.S. cents at 12:49 p.m. in Sydney.What Bloomberg Economics Says“Australia’s recession has ended, but the effects of the recession will take a long time to unwind. The rebound in 3Q recovered around 40% of the decline in output over 1H 2020, an impressive outcome given 25% of the economy remained locked down. The continued easing of restrictions over 4Q means the kick to growth from the normalisation of activity will be a key driver of GDP outcomes in 4Q 2020 and 1Q 2021. A recovery in private sector investment will be key to sustained growth beyond that point.”\-- James McIntyre, economistVictoria, which accounts for about 25% of GDP, was hit hard by efforts to contain a renewed outbreak of the virus. Its lockdown slashed A$100 million ($73.8 million) a day from activity and resulted in an average of 1,200 daily job losses across the state during August and September, Treasury estimated.“Victoria’s final demand fell 1%, the only state to record a decline, driven by decreases in household spending and investment,” the ABS said. “More stringent restrictions associated with the second lockdown resulted in a 9.8% fall through the year. Household spending declined 1.2% in September quarter.”Australia’s unemployment rate currently stands at 7% and the central bank expects it to climb closer to 8% as more Victorians return to the labor market hunting for jobs. At the same time, the return to growth brings an end to Australia’s first technical recession -- defined as two consecutive quarters of contraction -- in nearly 29 years.Today’s report showed:Household spending surged 7.9%, adding 4 percentage points to GDP; government spending rose 1.4%, contributing 0.3 percentage pointNet exports subtracted 1.9 percentage points from GDP, the largest detraction since September quarter 1980The savings rate eased to 18.9.% from an upwardly revised 22.1% in the second quarter, as government cash handouts and a dearth of spending options prompted households to repair their balance sheetsCompensation of employees rose 2.3% as hours worked increasedAustralia’s record run of avoiding two consecutive quarters of negative GDP had included avoiding recessions during the 1997 Asian Financial Crisis, the Dot-Com Bubble and the 2008 global financial crisis. With rates now near zero and the central bank running a quantitative easing program, it has rejoined the rest of the developed world in its policy struggles.The RBA and government are working in tandem to try to support the economy, with the former last month enacting further stimulus that included reducing interest rates to 0.10% and initiating a A$100 billion bond-buying program.“The board will continue to review the details of this package at our future meetings. We are prepared to do more, if that is required,” Lowe told lawmakers. “Having said that, we are still of the view that a negative policy interest rate in Australia is extraordinarily unlikely, with any benefits being outweighed by the costs.”Wednesday’s report showed private investment fell 0.2% as increased housing investment activity was offset by weaker business investment.“Ownership transfer costs increased 21.4%, as housing market activity rebounded,” the ABS said. “Renovations and home improvements activity drove a 5.1% rise in alterations and additions.”Australia has benefited from China’s stimulus to revive its economy this year, which has fueled commodity prices, helping the country to its sixth successive quarterly current-account surplus.Yet the bonanza with China, which takes about 35% of Australian exports, is under a cloud as relations between the two countries deteriorate. Beijing has slapped tariffs on some imports from Down Under, is refusing to take calls from ministers in Canberra, while gloating over alleged Australian war crimes.On top of that, commodity strength and Australia’s better position relative to many developed-world counterparts has sent the currency soaring. It’s up about 30% from a nadir of around 55 U.S. cents in March. One of the motivations behind the RBA’s QE program is to try to cool the Aussie dollar.Still, with households cashed up, the cost of borrowing at historic lows and Covid-19 contained for now, Australia’s economy is set for a much improved 2021. Consumer confidence is surging, hiring strengthening and the housing market is taking off once again.The RBA’s central scenario is for the economy to grow by 5% next year and then 4% over 2022.“It is certainly possible that the economy will do better than our central scenario,” Lowe said today, noting that doesn’t envisage a vaccine being widely available until late next year and significant restrictions on international travel still in place at the end of 2021.“Recent medical breakthroughs give us some hope that things will work out better than this,” the governor said. “If so, confidence would lift and there would be a further easing of restrictions. The result would be an upside surprise to growth and jobs, especially given the significant policy stimulus that is already in place.”(Updates with further detail from 10th paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The Manganese Mining Market will grow by 5385.13 K tons during 2020-2024
(Bloomberg) -- Hewlett Packard Enterprise Co. will move its headquarters to Houston, a major shift for a founding Silicon Valley computer maker now seeking haven in a lower-cost region while making way for a new generation of nimbler mobile and consumer-web giants.The company said it was already building a “state-of-the-art” new campus in Houston, the fourth-largest U.S. city. HPE also reported quarterly revenue that topped analysts’ predictions, suggesting that businesses are upgrading their data-center hardware during the coronavirus pandemic.HPE was created in the 2015 split of one of the consummate Bay Area technology companies, Hewlett-Packard Co., which was founded in 1939 in a Palo Alto garage. The move to Texas comes amid a broader re-evaluation, motivated by pandemic-enforced work-from-anywhere arrangements, by individuals and companies opting to leave behind a region known for its high cost of living and difficult commute.Chief Executive Officer Antonio Neri has been working to turn around HPE, a maker of servers, storage hardware and networking gear, which had reported declining revenue in all but one quarter since separating from personal-computer maker HP Inc. Neri is reducing the company’s overhead costs, exiting unprofitable businesses and chasing the hybrid-cloud market, in which businesses store and process some of their information in corporate data centers and some with public cloud companies.Sales in the quarter ended Oct. 31 were little changed from a year ago at $7.2 billion. Analysts, on average, estimated $6.9 billion, according to data compiled by Bloomberg. Profit, excluding some items, was 37 cents a share in the fiscal fourth quarter, HPE said Tuesday in a statement. Analysts had projected 34 cents.The spread of Covid-19 and the economic slowdown it triggered had suppressed demand for networking and computer hardware and services. Now that companies have settled into remote work for many employees, they’re investing in gear to make that more efficient.“The global pandemic has forced businesses to rethink everything from remote work and collaboration to business continuity and data insight,” Neri said in the statement. “We saw a notable rebound in our overall revenue, with particular acceleration in key growth areas of our business.”Hewlett Packard Enterprises follows a handful of other companies exiting at least in part from the San Francisco Bay Area. Newly public data-mining provider Palantir Technologies Inc. moved to Denver from Palo Alto earlier this year, while besieged e-cigarette maker Juul Labs Inc. is relocating to Washington from San Francisco. Charles Schwab Corp. said last year its headquarters will shift from San Francisco to Westlake, Texas. Many individuals, encouraged by laissez-faire work-from-home rules and put off by the cost of living in California, are also on the move.As Hewlett Packard Enterprises and its predecessor company receded from prominence in recent years, newer companies -- such as Alphabet Inc., Apple Inc. and Facebook Inc. -- have taken their place in the Silicon Valley pantheon.Fiscal fourth-quarter sales increased 6% from the prior period. In the current quarter, HPE projected that profit, excluding some items, will be 40 cents to 44 cents. That compares with an average analyst prediction of 35 cents, according to data compiled by Bloomberg. The company said sales will decline from the preceding period at a percentage in the mid-single digits, in line with normal seasonal patterns. A decline of 5% would indicate sales of about $6.84 billion. That compares with an average analyst estimate of $6.63 billion.The company will keep its technology innovation hub in San Jose, at a relatively new building, CEO Neri said on a conference call with analysts. Administrative work will be centered at the new Texas headquarters. Consolidating more expensive facilities in California will lead to real estate cost savings, he said.No staff reductions are associated with the move, HPE said in the statement. The company has locations in several cities in Texas, including Austin and Plano, and has more than 2,600 workers in Houston, according to a statement from the office of Governor Greg Abbott.HPE shares were little changed in extended trading after closing at $11.20 in New York. They have declined 29% this year.(Adds other companies leaving the Bay Area starting in eighth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Every time Elisa drives to a client's house for a hairdressing job, she makes sure to pack a bag of groceries in the car in case she is stopped by Greek police.
Yokogawa and Power Factors sign reseller agreement regarding Power Factors' Drive platform for renewable energy asset performance management.
NEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Kandi Technologies Group (NASDAQ: KNDI) on behalf of Kandi stockholders. Our investigation concerns whether Kandi has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action.On November 30, 2020, analyst Hindenburg Research published a report concerning Kandi Technologies Group, Inc., calling Kandi “a brazen scheme” that “falsif[ied] revenue using fake sales to undisclosed affiliates.” Hindenburg said that its report was based on “interviews with over a dozen former employees and business partners” of Kandi, as well as an “extensive on-the-ground inspection at Kandi's factories and customer locations in China.” Hindenburg asserted that approximately 64% of Kandi's sales in the last twelve months were to undisclosed related parties, and that Kandi “has consistently booked revenue it cannot collect, a classic hallmark of fake revenue.” On this news, Kandi's stock price fell sharply to close at $9.76 per share, a decline of approximately 28%. If you purchased or otherwise acquired Kandi shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Melissa Fortunato, Esq. Marion Passmore, Esq. (212) 355-4648 firstname.lastname@example.org www.bespc.com
NEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Mesoblast Limited (NASDAQ: MESO) securities between April 16, 2019 and October 1, 2020 (the “Class Period”). Investors have until December 7, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action.Mesoblast develops allogeneic cellular medicines using its proprietary mesenchymal lineage cell therapy platform. Its lead product candidate, RYONCIL (remestemcel-L), is an investigational therapy comprising mesenchymal stem cells derived from bone marrow. In February 2018, the Company announced that remestemcel-L met its primary endpoint in a Phase 3 trial to treat children with steroid refractory acute graft versus host disease (“aGVHD”).In early 2020, Mesoblast completed its rolling submission of its Biologics License Application (“BLA”) with the FDA to secure marketing authorization to commercialize remestemcel-L for children with steroid refractory aGVHD.On August 11, 2020, the FDA released briefing materials for its Oncologic Drugs Advisory Committee (“ODAC”) meeting to be held on August 13, 2020. Therein, the FDA stated that Mesoblast provided post hoc analyses of other studies “to further establish the appropriateness of 45% as the null Day-28 ORR” for its primary endpoint. The briefing materials stated that, due to design differences between these historical studies and Mesoblast’s submitted study, “it is unclear that these study results are relevant to the proposed indication.”On this news, the Company’s share price fell $6.09, or approximately 35%, to close at $11.33 per share on August 11, 2020.On October 1, 2020, Mesoblast disclosed that it had received a Complete Response Letter (“CRL”) from the FDA regarding its marketing application for remestemcel-L for treatment of SR-aGVHD in pediatric patients. According to the CRL, the FDA recommended that the Company “conduct at least one additional randomized, controlled study in adults and/or children to provide further evidence of the effectiveness of remestemcel-L for SR-aGVHD.” The CRL also “identified a need for further scientific rationale to demonstrate the relationship of potency measurements to the product’s biologic activity.”On this news, the Company’s share price fell $6.56, or 35%, to close at $12.03 per share on October 2, 2020.The complaint, filed on October 8, 2020, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that comparative analyses between Mesoblast’s Phase 3 trial and three historical studies did not support the effectiveness of remestemcel-L for steroid refractory aGVHD due to design differences between the four studies; (2) that, as a result, the FDA was reasonably likely to require further clinical studies; (3) that, as a result, the commercialization of remestemcel-L in the U.S. was likely to be delayed; and (4) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.If you purchased Mesoblast securities during the Class Period and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at email@example.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Melissa Fortunato, Esq. Marion Passmore, Esq. (212) 355-4648 firstname.lastname@example.org www.bespc.com
NEW YORK, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of Florida on behalf of investors that purchased Royal Caribbean Group (NYSE: RCL) securities between February 4, 2020 and March 17, 2020 (the “Class Period”). Investors have until December 7, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action.The complaint, filed on October 7, 2020, alleges that throughout the Class Period defendants failed to disclose material facts about the Company’s decrease in bookings outside China, instead maintaining that it was only experiencing a slowdown in bookings from China. The Action further alleges that defendants failed to disclose material facts about the Company’s inadequate policies and procedures to prevent the spread of COVID-19 on its ships. The truth about the scope of the impact that COVID-19 had on the Company’s overall bookings and the inability of Royal Caribbean to prevent the virus’ spread on its ships was revealed through a series of disclosures.First, on February 13, 2020, Royal Caribbean issued a press release stating that it had canceled 18 voyages in Southeast Asia due to recent travel restrictions and further warning that recent bookings had been softer for its broader business. On this news, Royal Caribbean shares fell over 3 percent.Second, on February 25, 2020, Royal Caribbean filed its 2019 Form 10-K, indicating that COVID-19 concerns were negatively impacting its overall business. On this news, Royal Caribbean shares fell over 14 percent.Third, on March 10, 2020, Royal Caribbean withdrew its 2020 financial guidance, increased its revolving credit facility by $550 million, and announced that it would take cost-cutting actions due to the proliferation of COVID-19, further revealing that COVID-19 was severely impacting Royal Caribbean’s 2020 customer booking and that its safety measures were inadequate to prevent the spread of the virus on its ships. On this news, Royal Caribbean shares fell over 14 percent.Fourth, on March 11, 2020, Royal Caribbean’s largest competitor, Carnival, announced a 60-day suspension of all operations, prompting concern that Royal Caribbean would follow suit. At the same time, Royal Caribbean also cancelled two cruises, beginning a series of cancellations and suspensions to follow. On this news, Royal Caribbean shares fell almost 32 percent.Fifth, on March 14, 2020, Royal Caribbean announced a suspension of all global cruises for 30 days. On this news, Royal Caribbean stock fell over 7 percent.Sixth, on March 16, 2020, the Company revealed that global operations could be suspended longer than anticipated, announcing the cancellations of two additional cruises throughout April and into May. On this news, Royal Caribbean shares fell over 7 percent.Finally, on March 18, 2020, analysts downgraded Royal Caribbean’s stock and slashed their price targets. On this news, Royal Caribbean shares fell more than 19 percent.If you purchased Royal Caribbean during the Class Period and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker, Melissa Fortunato, or Marion Passmore by email at email@example.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Melissa Fortunato, Esq. Marion Passmore, Esq. (212) 355-4648 firstname.lastname@example.org www.bespc.com
PHILADELPHIA, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Angeion Group today announced a partial settlement has been proposed in a legal matter concerning the Burley Tobacco Growers Cooperative Association (“the Co-op”) that would result in dissolving the Co-op and payments to certain tobacco growers in Kentucky, West Virginia, Ohio, Indiana, and Missouri. The payment is estimated to be $2000-$6000 for each eligible grower.If you grew burley tobacco in any of the 2015–2020 crop years in Kentucky, West Virginia, Ohio, Indiana, or Missouri, you could get money from a proposed settlement.What’s this about? The partial settlement stems from a lawsuit against the Co-op in Lexington, Kentucky, seeking, in part, the dissolution of the Co-op because of its alleged lack of any continuing purpose. You may have heard that a special meeting was called for Co-op members to vote on the Co-op’s dissolution. That special meeting was postponed and, if the settlement is given final approval, will be canceled.Who’s affected? Any person or business that was a landowner, operator, landlord, tenant, or sharecropper growing burley tobacco in Kentucky, West Virginia, Ohio, Indiana, or Missouri during at least one of the 2015-2020 crop years is a member of the settlement class. You should promptly check whether you are identified as a member of the settlement class by calling the number or visiting the website listed below. If you are not (but should be) identified as a settlement class member, there is a process to have your membership verified. You should complete the verification process by January 29, 2021. Information about how you verify membership is available through the number and website listed below.What is the proposed settlement? If this partial settlement is approved, the Co-op will be dissolved, and its assets will be liquidated, and debts paid. The net assets that will remain are estimated to be worth as much as $28 million. The Court will oversee the process. From the Co-op’s net assets, $1.5 million will be set aside to establish a farming related non-profit, costs relating to the administration of the settlement will be deducted, and a service award to representatives of the settlement class and attorney’s fees up to 25% of the net assets may be awarded by the Court. The assets that remain will then be paid out equally to members of the settlement class. If the partial settlement is approved, any claims you may have against the Co-op or its officers and directors will be released or limited. Details about the partial settlement and the release or limitation of claims are available by calling the number or visiting the website listed below.How do you get a money payment? After verifying your membership in the settlement class, submit a W-9 (tax i.d.) form as soon as possible, and no later than January 29, 2021. More information about getting a payment is available by calling the number or visiting the website listed below.What are your options? You must verify that you are a member and submit a W-9 to receive a payment. If you are a member of the settlement class and the partial settlement is approved by the Court, you will be bound by its terms even if you do not receive a payment. The Court will hold a hearing in this case — Haynes Properties, LLC, et al. v. Burley Tobacco Growers Cooperative Association, No. 20-CI-332, Fayette Circuit Court — on February 24, 2021, to consider whether to approve the partial settlement and award attorneys’ fees and other expenses. You have the right to object to the partial settlement and may attend, with or without an attorney, at the hearing, but you are not required to attend in order to potentially share in the money paid out.For more information, call toll free 1-855-965-5569, go to www.BTGCASettlement.com, or write to 1650 Arch Street, Suite 2210, Philadelphia, PA 19103. CONTACT: Media Contact: Angeion Group Douglas S. Clauson Director, Communications (215) 563-4116
Tasmania has received rare summer snowfall, while other parts of Australia battle a heatwave.
New Zealand's parliament is joining Japan, South Korea and several European nations in declaring a climate emergency.
Investors on the ASX have made little change to the main indices despite Australia emerging from its first recession in nearly 30 years.
Global climate policy debate is ramping up as Australia ponders a net zero emissions target, with a carbon price expected to be central to China's 2060 goal.
(Bloomberg) -- China’s No. 2 smartphone maker Xiaomi Corp. has suspended trading of its Hong Kong shares after completing the city’s largest top-up placement on record.Xiaomi said in a Hong Kong exchange filing that trading would be halted Wednesday, without giving a reason. While the company has yet to disclose its stock sale, deal terms obtained by Bloomberg News showed it sold 1 billion shares in a top-up placement at HK$23.70 each, the bottom of a range, to raise $3.1 billion. That represents a 9.4% discount to its last closing price of HK$26.15.A representative for Xiaomi didn’t immediately reply to a request for comment on the trading suspension. Hong Kong’s stock exchange requires a company to apply for a trading halt if certain inside information has been made public before an official disclosure.Wednesday’s premarket auction showed the stock trading as low as HK$24.50, implying a drop of 6.1%.“We are still figuring out the reason for the suspension,” said Castor Pang, head of research at Core Pacific-Yamaichi International Hong Kong. “It’s definitely unusual because other companies which had share placements usually file the official announcements soon after pricing. It’s hard to know what’s going on.”Xiaomi also fetched $900 million through the sale of a seven-year, zero-coupon convertible bond, the terms showed. The proceeds will add to a war chest aimed at expanding its market share from competitor Huawei Technologies Co.Xiaomi shares have rallied 143% this year. Its stock slipped after it disclosed that its internet services revenue had grown at its slowest pace in three years in the quarter that ended September. It grabbed market share from Huawei when American sanctions deepened particularly in overseas markets from Europe to India.The proceeds from the equity placement will be used for business expansion, investments to increase market share and strategic ecosystem investments, the terms showed.Credit Suisse Group AG, Goldman Sachs Group Inc, JPMorgan Chase & Co. and Morgan Stanley are arranging Xiaomi’s offering.(Adds attempt to contact company, exchange rules, premarket trading and quote from third paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Singapore has given U.S. start-up Eat Just the greenlight to sell its lab-grown chicken meat, in what the firm says is the world's first regulatory approval for so-called clean meat that does not come from slaughtered animals. Plant-based meat options, popularised by Beyond Meat Inc and Impossible Foods, increasingly feature on supermarket shelves and restaurant menus. "The first-in-the-world regulatory allowance of real, high-quality meat created directly from animal cells for safe human consumption paves the way for a forthcoming small-scale commercial launch in Singapore," Eat Just said on Wednesday.
The photo purportedly shows an Australian soldier drinking beer from the prosthetic leg of a dead Taliban soldier.
Jarryd Hayne couldn't get out of a woman's house quickly enough after injuring her vagina, the prosecutor has told the former NRL star's rape trial.
Electronics giant Samsung Electronics announced a small reshuffle of senior executives on Wednesday without replacing its recently deceased chairman or changing top leadership positions including that of vice chairman Jay Y. Lee. Heir apparent Lee, whose father and Samsung Electronics chairman Lee Kun-hee passed away in October, is currently facing two separate trials that analysts say could land him in jail for a second time. With the trials' uncertain outcomes hanging over Lee, Samsung is seen taking its time before making big changes in leadership positions such as Lee rising to fill the vacant chairmanship, analysts said.
The Pharmaceutical Caps and Closures Market will grow by USD 2.43 bn during 2020-2024